Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus, human HPRT, with GFP
Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system.
Supplier: Invitrogen™ A32060
Alert:
For Research Use Only. Not for use in diagnostic procedures.
Description
Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system. The Invitrogen™ LentiArray CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%.
The Invitrogen™ LentiArray CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%. It can be used to rapidly determine ideal delivery conditions in order to achieve maximum editing efficiency in your cell model of choice. This construct also expresses emGFP to provide a visual readout of successful transduction that can be used in determining Multiplicity of Infection (MOI).
Recommended Storage
Store at -68 to -85°C
Specifications
| 1 x 100 μL. Store (at -68°C to -85°C.) | |
| Tube | |
| gRNA | |
| Genome Editing | |
| gRNA | |
| 100 mL |
| Lentiviral | |
| Positive Control | |
| Human | |
| LentiArray™ | |
| U6 | |
| Dry Ice |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?